CD4-Th1-like cells expressing high levels of Tbx21, Gzmb, and Ifng (Fig. 5h; Supplementary Fig. 5c) had been shown to have anti-tumor capability through activating monocytes and responding to interferon-γ46. This evidence concerns the gene TBX21 and neoplasm.